Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PERIOGEN for Periodontal Bone Defect
NCT00496847Phase 3Completed
- Sponsor
- Virchow Group
- Start
- Aug 2007
- Primary completion
- Aug 2008
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of becaplermin in periodontitis, sponsored by Virchow Group. Started Aug 2007; status: completed.
02
Drugs
becaplermin
03
Conditions
periodontitis
Beyond the preview
Go deeper on NCT00496847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00496847.